Adv Drug Deliv Rev. 2006 Apr 20;58(1):52-67. Epub 2006 Mar 3.

Mucosal delivery of vaccine antigens and its advantages in pediatrics.

Source

Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161 Rome, Italy. mtdemagi@iss.it

Abstract

The delivery of vaccines through the mucosal route is very practical, non-invasive and efficacious for the induction of mucosal and systemic immune responses. Appropriately formulated mucosal vaccines can stimulate all arms of the immune system and could be exploited for protection against pathogens that infect the host through the mucosal surfaces as well as those acquired through other routes. There are few available mucosal vaccines so far and these are mainly based on whole microorganisms. The development of new generation mucosal vaccines based on purified protective antigens has been hampered for a long time by the low immunogenicity of soluble antigens and by the lack of safe and efficacious mucosal adjuvants. However, we have now several promising candidate adjuvants and delivery systems for mucosal immunization. In this review I will illustrate the advantages of mucosal vaccination and I will discuss what we still need to develop safe and efficacious mucosal vaccines that would be beneficial especially for young children.

PMID:: 16516335; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Immunization - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. [Immunol Cell Biol. 2004]
Review Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M, Srivastava I, Polo J, Donnelly J, O'Hagan D, Singh M. Immunol Cell Biol. 2004 Dec; 82(6):617-27.
Review Bioadhesive delivery systems for mucosal vaccine delivery. [J Drug Target. 2010]
Review Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC, O'Hagan DT. J Drug Target. 2010 Dec; 18(10):752-70. Epub 2010 Nov 2.
Review Mucosal immunisation: adjuvants and delivery systems. [Curr Drug Deliv. 2004]
Review Mucosal immunisation: adjuvants and delivery systems.
Moyle PM, McGeary RP, Blanchfield JT, Toth I. Curr Drug Deliv. 2004 Oct; 1(4):385-96.
Review New insights in mucosal vaccine development. [Vaccine. 2012]
Review New insights in mucosal vaccine development.
Pavot V, Rochereau N, Genin C, Verrier B, Paul S. Vaccine. 2012 Jan 5; 30(2):142-54. Epub 2011 Nov 12.
Review Generation of improved mucosal vaccines by induction of innate immunity. [Cell Mol Life Sci. 2005]
Review Generation of improved mucosal vaccines by induction of innate immunity.
Lavelle EC. Cell Mol Life Sci. 2005 Dec; 62(23):2750-70.

See reviews... See all...

Cited by 6 PubMed Central articles

Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. [Clin Vaccine Immunol. 2011]
Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.
Hamouda T, Sutcliffe JA, Ciotti S, Baker JR Jr. Clin Vaccine Immunol. 2011 Jul; 18(7):1167-75. Epub 2011 May 4.
Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells. [Infect Immun. 2011]
Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.
Veglia F, Sciaraffia E, Riccomi A, Pinto D, Negri DR, De Magistris MT, Vendetti S. Infect Immun. 2011 Mar; 79(3):1300-10. Epub 2010 Dec 13.
Probiotics and gastrointestinal disease: successes, problems and future prospects. [Gut Pathog. 2009]
Probiotics and gastrointestinal disease: successes, problems and future prospects.
Culligan EP, Hill C, Sleator RD. Gut Pathog. 2009 Nov 23; 1(1):19. Epub 2009 Nov 23.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Mucosal delivery of vaccine antigens and its advantages in pediatrics.
Mucosal delivery of vaccine antigens and its advantages in pediatrics.
Adv Drug Deliv Rev. 2006 Apr 20 ;58(1):52-67. Epub 2006 Mar 3 .

PubMed
CPAP interacts with 14-3-3 in a cell cycle-dependent manner.
CPAP interacts with 14-3-3 in a cell cycle-dependent manner.
Biochem Biophys Res Commun. 2006 Apr 21 ;342(4):1203-10. Epub 2006 Feb 24 .

PubMed
Improving general medical care for persons with mental and addictive disorders: ...
Improving general medical care for persons with mental and addictive disorders: systematic review.
Gen Hosp Psychiatry. 2006 Mar-Apr ;28(2):145-53.

PubMed
Using five questions to screen for five common mental disorders in primary care:...
Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector.
Gen Hosp Psychiatry. 2006 Mar-Apr ;28(2):108-18.

PubMed
How well does the Gleason score predict prostate cancer death? A 20-year followu...
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.
J Urol. 2006 Apr ;175(4):1337-40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: